PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) has announced a webcast conference call scheduled for Tuesday, May 6, at 4:30 p.m. ET. The call will present the company's first quarter 2025 financial results along with updates on business operations and future outlook.

Participants are advised to register in advance for dial-in details and join 15 minutes before the start time to avoid delays. The webcast will be accessible through PTC's investor relations website, with a replay available for 30 days after the call.

News Market Reaction

+2.11%

1 alert

+2.11% News Effect

On the day this news was published, PTCT gained 2.11%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., April 17, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2025 financial results and provide an update on the company's business and outlook on Tuesday, May 6, at 4:30 p.m. ET.

To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in for the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, X, and LinkedIn.

For more information please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-2025-financial-results-302428596.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics (PTCT) report Q1 2025 earnings?

PTC Therapeutics will report its Q1 2025 earnings on Tuesday, May 6, at 4:30 p.m. ET via a webcast conference call.

How can investors access PTC Therapeutics' Q1 2025 earnings call?

Investors can access the call by registering for dial-in details or through the Investors section at PTC's website (ir.ptcbio.com/events-presentations).

How long will PTC Therapeutics' Q1 2025 earnings call replay be available?

The earnings call replay will be archived on PTC's website for 30 days after the call.

What topics will be covered in PTC Therapeutics' Q1 2025 earnings call?

The call will cover Q1 2025 financial results, business updates, and the company's future outlook.